|
| ||
| Going back on meds Jun 23, 2002 I soon need to go back on meds. I am not resistant to anything. My doctor is suggesting Viracep, 3tc, d4t and Ziagen. Is this a strong enough combination considering that I have a viral load of over 700,000? If not please offer some alternatives. I cannot take ritonovir, AZT, crixivan and viramune due to side effects. Thanks |
||||||||||
|
|
Response from Dr. Young
Thanks for your question. This regimen should be a very potent regimen- though a detailed answer would require knowledge about what drugs you've been on in the past, and whether there was any concern about the presence of drug resistance. We know that triple nucleoside regimens (AZT, 3TC, abacavir) are quite potent and usually well tolerated-- there is little data about alternative triple nuke regimens, but it would be very reasonable to think that substituting d4T for AZT would be roughly equivalent. The addition of nelfinavir to this regimen should definately increase the potency- and address the concerns about triple nuke potency in persons with high viral loads, like yourself. Other possible medications to consider (without a strong basis for specific recommendation for you) might be tenofovir, ddI, and one of the boosted PI regimens, such as Kaletra (usually better tolerated than other boosted PIs). Good luck. -BY | |||||||||
Get Email Notifications When This Forum Updates or Subscribe With RSS
|
||||||||||
Q&A TERMS OF USE
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.
Review our complete terms of use and copyright notice.










